Strategic Diagnostics Posts 5 Percent Revenue Growth for Q3 | GenomeWeb
NEW YORK (GenomeWeb News) – Strategic Diagnostics reported after the close of the market yesterday that its third-quarter revenues increased around 5 percent to $6.9 million from $6.6 million.
 
The Newark, Del.-based antibody and proteomics research products firm said that its third-quarter revenues were positively impacted by a 38 percent increase in sales of food pathogen products, a 14 percent increase in sales of water and environmental products, and a 191 percent rise in genomic antibody technology sales.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.